Inventor · disambiguated record
Catharina Svanborg
Also filed as: SVANBORG CATHARINA
16 granted patents·19 pending applications·54 citations·filing 1998–2025
90Inventor score
Files withHAMLET PHARMA AB11LINNANE PHARMA AB7SELECTIMMUNE PHARMA AB6SVANBORG CATHARINA5NYA HAMLET PHARMA AB3
Top patents by PatentIndex Score
35 records- 0188US9085643B2Biologically active complex and its preparationSVANBORG CATHARINA·Filed 2011·Granted Jul 21, 2015·34 cites·15 claims
- 0278US7713533B2Active complex of α-lactalbumin (HAMLET) and cofactorNYA HAMLET PHARMA AB·Filed 2007·Granted May 11, 2010·1 cites·16 claims
- 0374US2025388889A1Lon protease, alpha-hemolysin, ck1-alpha-1; c-myb inhibitor or a cebp-delta inhibitor as therapeuticsLINNANE PHARMA AB·Filed 2025·Application pending·0 cites
- 0473US7524932B2Lactalbumin production processNYA HAMLET PHARMA AB·Filed 2006·Granted Apr 28, 2009·1 cites·47 claims
- 0572US2024156916A1Prophylactic and nutraceutical therapyHAMLET PHARMA AB·Filed 2023·Application pending·0 cites
- 0667US8796218B2Complex and production processSVANBORG CATHARINA·Filed 2010·Granted Aug 5, 2014·3 cites·16 claims
- 0766US11865161B2Prophylactic and nutraceutical therapyHAMLET PHARMA AB·Filed 2019·Granted Jan 9, 2024·0 cites·11 claims
- 0862US12331073B2Preparation of biologically active complexesHAMLET PHARMA AB·Filed 2021·Granted Jun 17, 2025·0 cites·11 claims
- 0962US9487561B2Biologically active complex and its preparationHAMLET PHARMA AB·Filed 2015·Granted Nov 8, 2016·1 cites·19 claims
- 1059US7270822B2Active complex of alpha-lactalbumin (hamlet) and cofactorNYA HAMLET PHARMA AB·Filed 2003·Granted Sep 18, 2007·4 cites·16 claims
- 1159US2025082625A1Novel therapySELECTIMMUNE PHARMA AB·Filed 2024·Application pending·0 cites
- 1258US2023055209A1Lon protease, alpha-hemolysin, ck1-alpha-1; c-myb inhibitor or a cebp-delta inhibitor as therapeuticsLINNANE PHARMA AB·Filed 2020·Application pending·0 cites
- 1357US6599874B1Protein complex from ion-exchange chromatography of casein for treatment of bacterial infectionsFiled 2000·Granted Jul 29, 2003·2 cites·13 claims
- 1454US2023372450A1Method for preparing a composition comprising an unfolded proteinLINNANE PHARMA AB·Filed 2021·Application pending·0 cites
- 1553US11103561B2Prophylactic and nutraceutical therapyHAMLET PHARMA AB·Filed 2013·Granted Aug 31, 2021·0 cites·8 claims
- 1651US2021252107A1Novel therapySELECTIMMUNE PHARMA AB·Filed 2021·Application pending·0 cites
- 1751US2022323391A1Combination of a chemotherapeutic agent and alpha-lactoglubulin-oleic acid complex for cancer therapyHAMLET PHARMA AB·Filed 2020·Application pending·0 cites
- 1851US2025241990A1Therapeutic agentSELECTIMMUNE PHARMA AB·Filed 2023·Application pending·0 cites
- 1950US11752192B2Inhibitor of RNA polymerase IISELECTIMMUNE PHARMA AB·Filed 2020·Granted Sep 12, 2023·0 cites·15 claims
- 2049US2006233807A1Novel therapies and methods of screening for therapeutic compoundsSVANBORG CATHARINA·Filed 2003·Application pending·0 cites
- 2148US11013786B2TherapySELECTIMMUNE PHARMA AB·Filed 2016·Granted May 25, 2021·0 cites·7 claims
- 2248US2007232550A1Use of Hamlet (Human Alpha-Lactalbumin Made Lethal to Tumour Cells) for Treating Viral InfectionsSVANBORG CATHARINA·Filed 2005·Application pending·0 cites
- 2346US7144855B2Protein complex from ion-exchange chromatography for treatment of bacterial infectionsHAMLET PHARMA AB·Filed 2003·Granted Dec 5, 2006·0 cites·14 claims
- 2446US2020140481A1Preparation of biologically active complexesHAMLET PHARMA AB·Filed 2018·Application pending·0 cites
- 2545US2020155534A1Novel therapyLINNANE PHARMA AB·Filed 2017·Application pending·0 cites
- 2644US10287585B2TherapyLINNANE PHARMA AB·Filed 2016·Granted May 14, 2019·0 cites·7 claims
- 2744US2019316135A1Novel therapyLINNANE PHARMA AB·Filed 2017·Application pending·0 cites
- 2843US2022252625A1Treatment and diagnosis of chronic inflammatory conditions in the lower urinary tractSELECTIMMUNE PHARMA AB·Filed 2020·Application pending·0 cites
- 2941US7053185B1Lactalbumin production processHAMLET PHARMA AB·Filed 1998·Granted May 30, 2006·6 cites·49 claims
- 3039US2020009222A1Therapeutically active complexesHAMLET PHARMA AB·Filed 2017·Application pending·0 cites
- 3139US2008039381A1Lactalbumin for Inhibiting AngiogenesisSVANBORG CATHARINA·Filed 2005·Application pending·0 cites
- 3236US2005085416A1Biologically active complexFiled 2003·Application pending·0 cites
- 3334US2009036368A1Therapeutic CombinationHAMLET PHARMA AB·Filed 2006·Application pending·0 cites
- 3434US2019240287A1Inhibitor of rna polymerase iiLINNANE PHARMA AB·Filed 2017·Application pending·0 cites
- 3529US6808930B1Therapeutic agentsFiled 1998·Granted Oct 26, 2004·2 cites·30 claims
Join the waitlist — get patent alerts
Get an alert when Catharina Svanborg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →